China Covid Booster
- All
- News
- Videos
-
China Needs "Good Covid Booster" Like Covovax, Says Adar Poonawalla
China needs a good COVID-19 booster vaccine like Covovax, but so far there hasn't been a positive response from China, said Chief Executive Officer of Serum Institute of India (SII), Adar Poonawalla on Wednesday.
-
Exclusive: "Telling China To Take Our Booster," Adar Poonawalla Tells NDTV
The Serum Institute of India is working to market its two key vaccines for Covid -- Covovax and Covishield -- in China, which is seeing a resurgence of the pandemic.
-
Nasal Vaccine Available From Today. Where You Can Get It
The government today approved the inclusion of an intranasal Covid vaccine in the vaccination programme as a booster dose for adults. The inclusion comes amid a surge in cases in China and some other countries.
-
China Lifting Covid Lockdown Could Kill Upto 2.1 Million People: Report
Between 1.3 and 2.1 million lives could be at risk if China lifts its zero-COVID policy given low vaccination and booster rates as well as a lack of hybrid immunity, according to London-based global health intelligence and analytics firm.
-
2nd Covid Booster Shot For High-Risk Groups, Elderly In China
China's National Health Commission (NHC) will roll out the second COVID-19 vaccine booster shots for high-risk groups and elderly people over 60 years old, it said in a statement on Wednesday.
-
Inhaled Covid Vaccine Gets Emergency Use Approval As Booster In China
China's CanSino Biologics Inc said on Sunday that its recently developed COVID-19 vaccine has been approved by the country's drug regulator for emergency use as a booster, potentially benefiting its business.
-
Coronavirus Highlights: Covishield, Covaxin Prices Cut To Rs 225
The prices of Covishield and Covaxin vaccines at private hospitals have been slashed by more than half. This comes a day before the Covid vaccine booster shots become available to all Indian adults.
-
India Now Considering Boosters For All Adults: Report
Last week, the health ministry urged Indian states to boost surveillance measures for the disease, citing a resurgence in some parts of Asia and Europe. Countries such as China and Italy have seen a recent rise in cases.
-
China's Sinovac Covid Booster Weaker Against Omicron, Hong Kong Study Shows
Three doses of Sinovac's CoronaVac COVID-19 vaccine do not produce adequate levels of antibodies to fight the Omicron variant of the coronavirus, researchers from Hong Kong said in a statement.
-
US Rebuffs WHO's Call For Covid Booster Jab Moratorium As China Curbs Travel
The United States rejected an appeal from the UN health agency on Wednesday for a moratorium on Covid-19 vaccine booster shots, while China tightened overseas travel curbs after recording its highest number of infections in six months.
-
China Needs "Good Covid Booster" Like Covovax, Says Adar Poonawalla
China needs a good COVID-19 booster vaccine like Covovax, but so far there hasn't been a positive response from China, said Chief Executive Officer of Serum Institute of India (SII), Adar Poonawalla on Wednesday.
-
Exclusive: "Telling China To Take Our Booster," Adar Poonawalla Tells NDTV
The Serum Institute of India is working to market its two key vaccines for Covid -- Covovax and Covishield -- in China, which is seeing a resurgence of the pandemic.
-
Nasal Vaccine Available From Today. Where You Can Get It
The government today approved the inclusion of an intranasal Covid vaccine in the vaccination programme as a booster dose for adults. The inclusion comes amid a surge in cases in China and some other countries.
-
China Lifting Covid Lockdown Could Kill Upto 2.1 Million People: Report
Between 1.3 and 2.1 million lives could be at risk if China lifts its zero-COVID policy given low vaccination and booster rates as well as a lack of hybrid immunity, according to London-based global health intelligence and analytics firm.
-
2nd Covid Booster Shot For High-Risk Groups, Elderly In China
China's National Health Commission (NHC) will roll out the second COVID-19 vaccine booster shots for high-risk groups and elderly people over 60 years old, it said in a statement on Wednesday.
-
Inhaled Covid Vaccine Gets Emergency Use Approval As Booster In China
China's CanSino Biologics Inc said on Sunday that its recently developed COVID-19 vaccine has been approved by the country's drug regulator for emergency use as a booster, potentially benefiting its business.
-
Coronavirus Highlights: Covishield, Covaxin Prices Cut To Rs 225
The prices of Covishield and Covaxin vaccines at private hospitals have been slashed by more than half. This comes a day before the Covid vaccine booster shots become available to all Indian adults.
-
India Now Considering Boosters For All Adults: Report
Last week, the health ministry urged Indian states to boost surveillance measures for the disease, citing a resurgence in some parts of Asia and Europe. Countries such as China and Italy have seen a recent rise in cases.
-
China's Sinovac Covid Booster Weaker Against Omicron, Hong Kong Study Shows
Three doses of Sinovac's CoronaVac COVID-19 vaccine do not produce adequate levels of antibodies to fight the Omicron variant of the coronavirus, researchers from Hong Kong said in a statement.
-
US Rebuffs WHO's Call For Covid Booster Jab Moratorium As China Curbs Travel
The United States rejected an appeal from the UN health agency on Wednesday for a moratorium on Covid-19 vaccine booster shots, while China tightened overseas travel curbs after recording its highest number of infections in six months.
